The 2nd Digital Biomarkers and Clinical Measures in Neurology Summit covers topics such as:
THE CURRENT STATE OF PLAY OF NEUROLOGICAL DIGITAL MEASURES TO DRIVE CROSS-STAKEHOLDER VALIDATION & ADOPTION
A Smartphone-Based Application for Quantitative Fine Motor Assessment
Can Digital Clinical Measures Accelerate Alzheimer’s Disease Drug Development? Key Considerations & Opportunities
What are the Current Unmet Needs in Tackling Neurological Diseases that Digital Biomarkers can Fill?
THE PATH FOR THE VALIDATION OF DIGITAL BIOMARKERS TO COMBAT POOR ANCHORS IN NEUROLOGICAL INDICATIONS
Validating Neurological Digital Measures Using Real World Evidence & Remotely Collected Data
Leveraging Machine Learning & AI to Analyse Datasets & Identify Digital Biomarkers
Establishing Novel Anchors for Validating Digital Biomarkers in Neurological Indications
STRATEGIES TO VALIDATE DIGITAL MEASURES USING RWE & INCORPOARTE INTO EXISTING CLINICAL FRAMEWORKS
How to Choose Technology & Data Measurements for Developing Ideal Digital Biomarkers
Validating Digital Measures in Neurological Conditions: Lessons Learned from Technology-based Assessments of Upper Limb Disability
Harnessing Real World Evidence from Remote Patient Assessments to Validate Digital Biomarkers for Neurological Conditions
Understanding Strategies to Integrate Digital Tools with Enhanced Analytical Capabilities into Established Clinical Trials
EXPLORING STRATEGIES TO VALIDATE DIGITAL MEASURES USING RWE & INCORPOARTE INTO EXISTING CLINICAL FRAMEWORKS
How to Choose Technology & Data Measurements for Developing Ideal Digital Biomarkers
Validating Digital Measures in Neurological Conditions: Lessons Learned from Technology-based Assessments of Upper Limb Disability
Harnessing Real World Evidence from Remote Patient Assessments to Validate Digital Biomarkers for Neurological Conditions
Understanding Strategies to Integrate Digital Tools with Enhanced Analytical Capabilities into Established Clinical Trials
MAKING IT A REALITY: SHOWCASING DIGITAL MEASURES FOR INTERVENTION ACROSS NEURODEGENERATION
Exploring Digital Biomarker Research in Neurodegenerative Diseases
Advancing a Medical Device Technology to Slow Cognitive Decline and Modify Disease Progression in Alzheimer’s Disease
Quantifying Digital Measures to Validate Digital Biomarkers for Parkinson’s Disorders
Leveraging Digital Biomarkers in Intervention & Drug Design Applications Across Different Neurological Indications
EVALUATING DATA COLLECTION DEVICES TO OPTIMIZE PATIENT USABILITY & DATA QUALITY
Utilizing Wearable Technologies for Digital Clinical Measures of Activity & Gait
Evaluating the Use of Wearable Technologies in Decentralized Clinical Trials & Applying Learnings to Ongoing Large Scale Studies
Considering Device Burden & Usability to Maximise Patient Compliance in Neurological Clinical Trials
UTILIZING PATIENT CENTRIC CO-CREATION TO DESIGN CLINICALLY MEANINGFUL DIGITAL MEASURES
Exploring a Digital Cognitive Assessment to Incorporate into Routine Patient Care
Establishing a Dialogue to Understand Priorities & Experiences from Clinical Trial Participation for Digital Measures
Past Events
2nd Digital Biomarkers and Clinical Measures in Neurology Summit - 11-13 Jul 2023, Hilton Boston Logan Airport, Massachusetts, United States (99382)
Important
Please, check "Digital Biomarkers and Clinical Measures in Neurology Summit" official website for possible changes, before making any traveling arrangements